Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator[1].
Molecular Weight:
(145.743 kDa)
Purity:
99.9
CAS Number:
[2473240-98-9]
Target:
TGF-beta/Smad
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted